The answer to Parkinson’s and Alzheimer’s is all in your eyes
A new AI platform can accelerate and improve drug development, monitoring, and care for neurological disorders using information from the eyes captured via smartphone or webcam.
A new AI platform can accelerate and improve drug development, monitoring, and care for neurological disorders using information from the eyes captured via smartphone or webcam.
Israeli researchers combine two FDA-approved drugs to protect the blood-brain-barrier and thus prevent development of brain pathologies.
Big Panda, Spot.IM, SCADAfence, Arbe Robotics, Buildup among other Israeli startups that received investments over the course of the month.
Israeli researchers say monitoring the motion of eyelids can help diagnose eye diseases and neurological diseases, including Parkinson’s.
Largest ever acquisition of an Israeli healthcare company is to be made by Japan’s Mitsubishi Tanabe Pharma Corporation.
500 China-Israel B2B meetings held during 15th annual Israel Biomed Conference.
New neurological findings from Israel show it is possible to self-teach a non-emotional way of putting the brakes on emotional reactions.
Neuronix’s neuroAD is already commercially available in Europe, Asia and Israel for slowing disease progression in mild to moderate Alzheimer cases.
The current round of terror attacks has done nothing to stop brain scientists from Israel and Arab countries cooperating for unique conferences.
The small Israeli pharma company NeuroRx is testing a novel compound of two existing drugs to quash suicidal feelings.
‘This conference — this magnitude and scale — I have never seen anything like it in the world,’ says participant from Brown University.
ISRAEL21c brings you the country’s top 64 innovations — developments that are transforming and enriching lives across the planet.
In an impressive year for Israeli science, ISRAEL21c reviews some of its most popular stories of the year, from breakthroughs in cancer, to mind-controlled computing and solar windows.